TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang(Shandong University), Enyu Liu(Shandong University)Scientific ReportsNovember 2, 202410.1038/s41598-024-78316-3Cited by 2SaveCiteExport RISWatch citationsRelated PapersSuppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma|PLoS ONE|2013|60TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways|Research Square|2024|0